Helius Medical amends bylaws: quorum cut to one-third, universal proxy rules adopted

Solana Co

Quorum requirement reduced from majority to one-third of voting power for stockholder meetings.
Universal proxy rules adopted per SEC Rule 14a-19; only Board nominees allowed unless complying.
Enhanced disclosure for stockholder director nominations and proposals; board may request additional info.
Special meeting nomination requires 10% voting power; stockholder status at notice and record date.
Technical and clarifying changes to reflect updates in Delaware General Corporation Law.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Solana Co: Amended and restated bylaws to reduce stockholder meeting quorum, address universal proxy rules, update disclosure requirements, impose new special meeting nomination conditions, and clarify personal jurisdiction (effective 2024-03-12).

Change: bylaw amendment
Effective: 2024-03-12

Exact text from the filing

On March 12, 2024, the Board of Directors (the “ Board ”) of Helius Medical Technologies, Inc., a Delaware corporation (the “ Company ”) approved and adopted the Company’s Second Amended and Restated Bylaws (the “ Second Amended and Restated Bylaws ”), which became effective the same day.

View on SEC.gov

268 governance changes filed in the last 30 days. Browse all governance changes →

Solana Co filing history →

Source: SEC EDGAR

accession 0001558370-24-003414

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.